Publication Month: May 2021 | Report Code: TIPRE00022432 | No. of Pages: 218 | Category: Medical Device | Status: Published
Biological enzymes catalyze various chemical reactions in biological systems. Non-invasive or non-surgical aesthetic treatment procedures do not involve any kind of surgical incision. In some cases, minimally invasive surgeries are also categorized under non-surgical procedures. A few of the commonly conducted non-invasive aesthetic treatment includes botulinum toxin injection, chemical peels, non-surgical laser treatment, and microdermabrasion. The rising number of non-invasive aesthetic/cosmetic procedures performed every year, surge in awareness about cosmetic procedures among consumers, and availability of technologically advanced products are the key factors contributing to the non-invasive aesthetic treatment market growth. However, clinical risks and complications associated with medical aesthetic procedures restrain the market growth.
The non-invasive aesthetic treatment market is witnessing slump amid the COVID-19 pandemic. Most healthcare research organizations and hospitals are engaged in introducing new products and solutions for the effective management of the disease. In addition, governments have issued guidelines for the rescheduling or suspension of all elective surgeries with an aim to focus completely on handling the COVID-19 pandemic. This is hampering the demand for non-invasive aesthetic treatments, thus limiting the market growth.
Non-surgical cosmetic procedures do not involve making surgical incisions and usually are considered minimally invasive. The availability of user-friendly, high-tech products is contributing to the rise in adoption of aesthetic treatments. Several manufacturers are working on advanced non-invasive aesthetic treatment products. For instance, In January 2021, Galderma launched the Face for Change program to positively impact communities around the US, in cooperation with Dress for Success and The Skin Cancer Foundation. This purpose-driven program would enable users of Dysport (abobotulinumtoxinA) for injection to give after every treatment.
Similarly, in June 2020, Sciton Inc. launched a new products platform mJOULE. It includes a new technology such as MOXI, and BBL HERO, and it is one of the most significant improvements in pulsed light-based technology. MOXI conveniently presents the application of non-ablative laser energy to revitalize skin, irrespective of the season, age, or skin type.
Furthermore, in October 2020, Alma launched its latest Alma Hybrid platform, designed to explore multiple possibilities of using ablative, non-ablative, and thermal treatments, along with testing their synergistic impact, on skin rejuvenation and scar revision. Therefore, the availability of technologically advanced non-invasive aesthetic treatment products is fueling the non-invasive aesthetic treatment market growth.
Based on procedure, the non-invasive aesthetic treatment market is segmented into injectables, skin rejuvenation, and others. The injectables segment held the largest larger market share in 2020, and it is estimated to register the highest CAGR during the forecast period. Factors such as the increasing number of product approvals and launches, rising awareness regarding the benefits of injectables, and overall growth in number of cosmetic surgeries are bolstering the market for this segment. The market for injectables is further segmented into botulinum toxin, calcium hydroxyapatite, hyaluronic acid, polymer filler, and collagen. Further, the market for skin rejuvenation is subsegmented into chemical peel, laser skin resurfacing, and photo rejuvenation. The others segment includes hair removal, nonsurgical fat reduction, sclerotherapy, and cellulite treatment.
Based on end user, the non-invasive aesthetic treatment market is segmented into hospitals, clinics and medical spas, and others. In 2020, the hospitals segment held the largest share of the market; it is further estimated to register the highest CAGR of 14.9% during the forecast period.
|Market Size Value in||US$ 6,504.19 Million in 2020|
|Market Size Value by||US$ 18,656.54 Million by 2028|
|Growth rate||CAGR of 14.2% from 2021-2028|
|No. of Pages||218|
|No. of Tables||139|
|No. of Charts & Figures||81|
|Historical data available||Yes|
|Segments covered||Procedure and End-User , and Geography|
|Regional scope||North America, Europe, Asia Pacific, Middle East & Africa, South & Central America|
|Country scope||US, Canada, Mexico, UK, Germany, Spain, Italy, France, India, China, Japan, South Korea, Australia, UAE, Saudi Arabia, South Africa, Brazil, Argentina|
|Report coverage||Revenue forecast, company ranking, competitive landscape, growth factors, and trends|
|Free Sample Copy Available|
The non-invasive aesthetic treatment market players are adopting the product launch and expansion strategies to meet changing customer demands, which further allows them to maintain their brand name globally.
The List of Companies - Non-Invasive Aesthetic Treatment Market